B-intervention	0	3	Web
I-intervention	3	4	-
I-intervention	4	9	Based
I-intervention	10	18	Tailored
I-intervention	19	34	Psychoeducation
O	35	38	for
O	39	45	Breast
O	46	52	Cancer
O	53	61	Patients
O	62	64	at
O	65	68	the
O	69	74	Onset
O	75	77	of
O	78	81	the
O	82	94	Survivorship
O	95	100	Phase
O	100	101	:
O	102	103	A
O	104	115	Multicenter
O	116	126	Randomized
O	127	137	Controlled
O	138	143	Trial
O	143	144	.

O	145	149	Many
O	150	156	breast
O	157	163	cancer
O	164	172	patients
O	173	177	have
O	178	183	unmet
O	184	197	informational
O	198	201	and
O	202	214	psychosocial
O	215	220	needs
O	221	226	after
O	227	236	treatment
O	237	247	completion
O	247	248	.

O	249	250	A
O	251	268	psychoeducational
O	269	281	intervention
O	282	285	may
O	286	288	be
O	289	293	well
O	294	300	suited
O	301	303	to
O	304	311	support
O	312	317	these
O	318	326	patients
O	326	327	.

O	328	331	The
O	332	339	purpose
O	340	342	of
O	343	347	this
O	348	359	multicenter
O	360	370	randomized
O	371	381	controlled
O	382	387	trial
O	388	391	was
O	392	394	to
O	395	402	examine
O	403	406	the
O	407	420	effectiveness
O	421	423	of
O	424	425	a
O	426	429	web
O	429	430	-
O	430	435	based
O	436	444	tailored
O	445	462	psychoeducational
O	463	470	program
O	471	472	(
O	472	481	ENCOURAGE
O	481	482	)
O	483	486	for
O	487	493	breast
O	494	500	cancer
O	501	509	patients
O	509	510	,
O	511	516	which
O	517	521	aims
O	522	524	to
O	525	532	empower
O	533	541	patients
O	542	544	to
O	545	549	take
O	550	557	control
O	558	562	over
O	563	573	prevailing
O	574	582	problems
O	582	583	.

O	584	590	Female
O	591	597	breast
O	598	604	cancer
O	605	613	patients
O	614	618	from
O	619	622	two
O	623	632	hospitals
O	633	635	in
B-location	636	639	The
I-location	640	651	Netherlands
B-eligibility	652	655	who
I-eligibility	656	664	recently
I-eligibility	665	674	completed
I-eligibility	675	676	(
I-eligibility	676	679	neo
I-eligibility	679	680	-
I-eligibility	680	681	)
I-eligibility	681	689	adjuvant
I-eligibility	690	702	chemotherapy
O	703	707	were
O	708	716	randomly
O	717	725	assigned
O	726	728	to
B-control	729	737	standard
I-control	738	742	care
O	743	745	or
O	746	748	12
O	748	749	-
O	749	753	week
O	754	760	access
O	761	763	to
O	764	767	the
O	768	777	ENCOURAGE
O	778	785	program
O	786	795	providing
O	796	801	fully
O	802	811	automated
O	812	823	information
O	824	831	problem
O	831	832	-
O	832	839	solving
O	840	850	strategies
O	850	851	,
O	852	861	resources
O	861	862	,
O	863	866	and
O	867	875	services
O	876	879	for
O	880	888	reported
O	889	897	problems
O	897	898	.

O	899	901	At
O	902	905	six
O	906	909	and
O	910	912	12
O	913	918	weeks
O	918	919	,
O	920	928	patients
O	929	938	completed
B-outcome-Measure	939	943	self
I-outcome-Measure	943	944	-
I-outcome-Measure	944	950	report
I-outcome-Measure	951	960	questions
I-outcome-Measure	961	963	on
I-outcome-Measure	964	972	optimism
I-outcome-Measure	973	976	and
I-outcome-Measure	977	984	control
I-outcome-Measure	985	989	over
I-outcome-Measure	990	993	the
I-outcome-Measure	994	1000	future
O	1001	1002	(
O	1002	1009	primary
O	1010	1017	outcome
O	1017	1018	)
O	1018	1019	,
B-outcome-Measure	1020	1028	feelings
I-outcome-Measure	1029	1031	of
I-outcome-Measure	1032	1037	being
I-outcome-Measure	1038	1046	informed
O	1046	1047	,
O	1048	1051	and
B-outcome-Measure	1052	1062	acceptance
I-outcome-Measure	1063	1065	of
I-outcome-Measure	1066	1069	the
I-outcome-Measure	1070	1077	illness
I-outcome-Measure	1077	1078	.

O	1079	1081	At
O	1082	1090	baseline
O	1091	1094	and
O	1095	1097	12
O	1098	1103	weeks
O	1103	1104	,
O	1105	1113	distress
O	1114	1117	and
O	1118	1125	quality
O	1126	1128	of
O	1129	1133	life
O	1134	1148	questionnaires
O	1149	1153	were
O	1154	1163	completed
O	1163	1164	.

O	1165	1170	About
B-total-participants	1171	1174	138
O	1175	1183	patients
O	1184	1188	were
O	1189	1197	included
O	1197	1198	.

O	1199	1205	Almost
O	1206	1209	all
O	1210	1218	patients
O	1219	1220	(
B-iv-bin-abs	1220	1222	67
O	1223	1225	of
B-intervention-participants	1226	1228	69
O	1228	1229	)
B-outcome	1230	1237	visited
I-outcome	1238	1247	ENCOURAGE
I-outcome	1248	1250	as
I-outcome	1251	1260	requested
O	1260	1261	.

O	1262	1264	No
O	1265	1276	differences
O	1277	1284	between
O	1285	1288	the
O	1289	1296	control
O	1297	1300	and
O	1301	1313	intervention
O	1314	1319	group
O	1320	1324	were
O	1325	1333	observed
O	1334	1337	for
O	1338	1345	primary
O	1346	1349	and
O	1350	1359	secondary
O	1360	1368	outcomes
O	1368	1369	.

O	1370	1372	An
O	1373	1382	unplanned
O	1383	1391	subgroup
O	1392	1400	analysis
O	1401	1407	showed
O	1408	1412	that
O	1413	1415	in
O	1416	1426	clinically
O	1427	1437	distressed
O	1438	1446	patients
O	1447	1448	(
O	1448	1449	N
O	1450	1451	=
O	1452	1454	57
O	1455	1457	at
O	1458	1466	baseline
O	1466	1467	;
O	1468	1470	41
O	1470	1471	%
O	1471	1472	)
O	1472	1473	,
O	1474	1477	use
O	1478	1480	of
O	1481	1484	the
O	1485	1494	ENCOURAGE
O	1495	1502	program
B-outcome	1503	1512	increased
I-outcome	1513	1521	optimism
I-outcome	1522	1525	and
I-outcome	1526	1533	control
I-outcome	1534	1538	over
I-outcome	1539	1542	the
I-outcome	1543	1549	future
O	1550	1552	at
O	1553	1555	12
O	1556	1561	weeks
O	1562	1566	more
O	1567	1571	than
O	1572	1574	in
O	1575	1583	patients
O	1584	1586	in
O	1587	1590	the
O	1591	1598	control
O	1599	1604	group
O	1605	1606	(
O	1606	1611	Cohen
O	1611	1612	'
O	1612	1613	s
O	1614	1615	d
O	1616	1617	=
O	1618	1619	0
O	1619	1620	.
O	1620	1622	65
O	1622	1623	)
O	1623	1624	.

O	1625	1633	Although
O	1634	1637	the
O	1638	1651	effectiveness
O	1652	1655	was
O	1656	1659	not
O	1660	1672	demonstrated
O	1672	1673	,
O	1674	1675	a
O	1676	1684	subgroup
O	1685	1687	of
O	1688	1693	women
O	1694	1701	treated
O	1702	1705	for
O	1706	1712	breast
O	1713	1719	cancer
O	1720	1723	can
O	1724	1732	probably
O	1733	1735	be
O	1736	1745	supported
O	1746	1748	by
O	1749	1752	the
O	1753	1760	program
O	1760	1761	.

O	1762	1765	The
O	1766	1773	results
O	1774	1776	of
O	1777	1780	the
O	1781	1788	present
O	1789	1794	study
O	1795	1798	are
O	1799	1800	a
O	1801	1809	starting
O	1810	1815	point
O	1816	1819	for
O	1820	1827	further
O	1828	1839	development
O	1840	1843	and
O	1844	1847	use
O	1848	1850	of
O	1851	1854	the
O	1855	1862	program
O	1862	1863	.
